1. Home
  2. CBLL vs PLSE Comparison

CBLL vs PLSE Comparison

Compare CBLL & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBLL
  • PLSE
  • Stock Information
  • Founded
  • CBLL 2014
  • PLSE 2014
  • Country
  • CBLL United States
  • PLSE United States
  • Employees
  • CBLL N/A
  • PLSE 56
  • Industry
  • CBLL
  • PLSE Medical/Dental Instruments
  • Sector
  • CBLL
  • PLSE Health Care
  • Exchange
  • CBLL Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • CBLL 1.0B
  • PLSE 1.2B
  • IPO Year
  • CBLL 2024
  • PLSE 2016
  • Fundamental
  • Price
  • CBLL $27.40
  • PLSE $19.31
  • Analyst Decision
  • CBLL Strong Buy
  • PLSE
  • Analyst Count
  • CBLL 5
  • PLSE 0
  • Target Price
  • CBLL $33.25
  • PLSE N/A
  • AVG Volume (30 Days)
  • CBLL 167.8K
  • PLSE 174.5K
  • Earning Date
  • CBLL 11-12-2024
  • PLSE 10-30-2024
  • Dividend Yield
  • CBLL N/A
  • PLSE N/A
  • EPS Growth
  • CBLL N/A
  • PLSE N/A
  • EPS
  • CBLL N/A
  • PLSE N/A
  • Revenue
  • CBLL $60,041,000.00
  • PLSE N/A
  • Revenue This Year
  • CBLL $44.86
  • PLSE N/A
  • Revenue Next Year
  • CBLL $26.56
  • PLSE N/A
  • P/E Ratio
  • CBLL N/A
  • PLSE N/A
  • Revenue Growth
  • CBLL 131.62
  • PLSE N/A
  • 52 Week Low
  • CBLL $23.00
  • PLSE $6.60
  • 52 Week High
  • CBLL $32.75
  • PLSE $22.69
  • Technical
  • Relative Strength Index (RSI)
  • CBLL N/A
  • PLSE 54.83
  • Support Level
  • CBLL N/A
  • PLSE $16.35
  • Resistance Level
  • CBLL N/A
  • PLSE $20.69
  • Average True Range (ATR)
  • CBLL 0.00
  • PLSE 1.36
  • MACD
  • CBLL 0.00
  • PLSE -0.04
  • Stochastic Oscillator
  • CBLL 0.00
  • PLSE 54.31

About CBLL CeriBell Inc. Common Stock

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: